Documents

November 2013

• White House Transcript Of President's Comments On Plan Cancellations
• GOP Senators To Administration: No Union Carveouts From Obamacare
• CMS Outlines Administration's Plan Cancellation Fix In Letter To Insurance Commissioners
• Lawmakers Say They Intended To Give FDA Flexibility In Deciding Biosimilar Naming
• HHS Says 106K Picked An Exchange Plan In First Month Of Open Enrollment
• CBO Report Outlines Options For Cutting Deficit
• Chamber Of Commerce Survey Finds Fewer Full-Time Workers Due To ACA
• CBO Report Options For Reducing The Deficit: 2014 To 2023
• Stakeholders React To Bicameral, Bipartisan SGR Repeal Plan
• Business Roundtable Urges Ongoing Flexibility On ACA Reporting Rules
• Bipartisan Group Of Senators Seek GAO Report On Federal Agencies' Regenerative Medicine Policies
• Top Agency Official Explains Recordkeeping Proposed Rule
• FDA Releases Strategic Plan To Avert Drug Shortages
• Reactions To FDA's Generic Drug Labeling Rule
• AIHA Lauds Issuance Of Silica Proposed Rule
• Michigan Submits 1115 Waiver Request For Medicaid Expansion
• FDA Proposes Rule Allowing Generic Drugmakers To Make Labeling Changes That Differ From Brands
• OSHA Chief Focuses On Temp Worker Protections
• White House Berates 24 States Refusing To Expand Medicaid
• American Academy Of Actuaries Warns Individual Mandate Delay Would Hike Premiums
• Proposed OSHA Rule On Electronic Records
• FDA Says Partially Hydrogenated Oils Are Not GRAS
• FDA Issues FY 2014 Device Guidance Priorities
• Internal CMS Memo Announces Information Office Leadership Changes
• Tavenner Response To Camp Subpoena Threat